Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 46.00
-2.00 (-4.17%)
At close: Jul 29, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 2.67 billion as of July 29, 2026. Its market cap has decreased by -8.35% in one year.
Market Cap
2.67B
Enterprise Value
2.28B
Revenue
222.03M
Ranking
n/a
PE Ratio
101.50
Stock Price
46.00
ChartMarket Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 2.67B, an increase of 91.94%. That is a compound annual growth rate of 38.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 2.67B | -25.45% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 28.85B |
| HanchorBio | 18.36B |
| Elixiron Immunotherapeutics (Cayman) Limited | 10.98B |
| Intelligene | 7.08B |
| Uwell Biopharma | 6.83B |
| Tripartite Therapeutics | 5.92B |
| Obigen Pharma | 3.85B |
| BIONET Therapeutics | 2.16B |